New York, NY (PRWEB) May 10, 2014
A California federal judge has stayed a DePuy Pinnacle hip lawsuit (http://www.depuypinnacle-lawsuit.com/) originally filed in San Francisco County Superior Court, pending its possible transfer to the federal multidistrict litigation underway in U.S. District Court, Northern District of Texas. According to an Order dated April 23, 2014, the Pinnacle lawsuit was conditionally transferred to the federal litigation via an Order issued by the U.S. Judicial Panel on Multidistrict Litigation (JPML) on March 25, 2014, a move which plaintiffs oppose. In his April 23rd Order, U.S. District Judge Samuel Conti of the Northern District of California wrote that the stay will avoid unnecessarily duplicative discovery and inconsistent court rulings while the federal court’s decision on the final transfer is pending. (Sobera, et al. v. DePuy Orthopaedics Inc., et al., No. 14-979)
“Our Firm is representing numerous Pinnacle hip lawsuit clients whose cases share similarities with this claim. We also continue to hear from individuals who were allegedly injured by the all-metal Pinnacle hip on a regular basis,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of dangerous drugs and medical devices. The Firm continues to offer free case reviews to individuals who may have been injured by the all-metal DePuy Pinnacle hip implant.
Pinnacle Hip Lawsuits
According to court documents, all of the Pinnacle hip lawsuits pending in the Northern District of Texas involve a metal-on-metal version of the Pinnacle Hip Replacement System that includes the Ultamet Liner. Plaintiffs claim that this design makes them vulnerable to metallosis, pseudotumor formation, early failure of the hip, and other complications due to its propensity to shed toxic metal ions into the tissue surrounding the device, as well as the blood stream. They also claim that the all-metal Pinnacle suffers from the same design flaws that prompted Johnson & Johnson and its DePuy Orthopaedics unit to recall ASR hip implants in 2010. Jeffrey S. Grand, a partner with Bernstein Liebhard LLP, is serving on the Plaintiffs’ Steering Committee in the federal Pinnacle litigation. (In re: DePuy Orthopaedics Inc. Pinnacle Hip Implant Product Liability Litigation, MDL No. 2244)
While there has not been a DePuy Pinnacle hip recall for this device, Johnson & Johnson and DePuy Orthopaedics did announce in May 2013 that they would cease the sale of metal-on-metal hip implants, including the device involved in Pinnacle hip lawsuits. The companies’ action followed an alert issued by the U.S. Food & Drug Administration (FDA) in January 2013, which warned that metal-on-metal hips were more likely to fail early than those made of other materials. The agency also revealed that it was considering new rules that would subject the all-metal hips to greater regulatory oversight.
Individuals who suffered serious complications allegedly associated with the metal-on-metal Pinnacle hip implant may be entitled to compensation. Find out more about filing a DePuy Pinnacle lawsuit by visiting Bernstein Liebhard LLP’s website. To arrange for a free, no obligation review of your case, please call 800-511-5092 today.
*bloomberg.com/news/2013-05-16/j-j-will-stop-sales-of-metal-on-metal-hip-replacements.html, Bloomberg.com, May 17, 2013
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP represents the victims of defective drugs and medical devices on a contingency-fee basis, and our clients are never expected to pay attorneys fees unless their case results in a successful recovery on their behalf. New York State’s contingency fee cap rules generally limit those fees to 33 1/3% of the total recovery. As a result, the Firm’s fees can be significantly lower than those assessed by attorneys in other states, which depending on the law may amount to as much as 40% or more of a plaintiff’s recovery.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP